Pfizer, Inc. price

€25.53€0.00 (--)
Last updated on Nov 20, 2026, 23:01:40.
Market cap
€142.78B
Circulating supply
--
All-time high
€25.9
24h volume
€459.91

Trusted by 100M+ globally

Find out why

About Pfizer, Inc.

Pfizer Inc. is a global biopharmaceutical leader engaged in the research, development, production, marketing, and distribution of a wide array of medicinal and vaccine products worldwide. Its comprehensive portfolio addresses diverse therapeutic areas, including cardiovascular health and women's health, featuring key brands such as the Premarin family and Eliquis. The company also offers advanced biologics, small molecule drugs, immunotherapies, and biosimilars for various conditions, exemplified by Ibrance, Xtandi, and Retacrit. Furthermore, Pfizer provides sterile injectables, anti-infective agents, and a significant oral treatment for COVID-19, including Paxlovid. A substantial portion of its offerings comprises vaccines for infectious diseases such as pneumococcal and meningococcal disease, tick-borne encephalitis, and COVID-19, with notable products like Comirnaty and the Prevnar family. The firm also develops biosimilars for chronic autoimmune and inflammatory disorders, including Inflectra and Xeljanz, alongside specialized therapies for rare conditions like amyloidosis, hemophilia, and endocrine disorders, under brands such as Vyndaqel and BeneFIX. Beyond its proprietary products, Pfizer operates a contract manufacturing division. Its extensive customer base includes wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual medical practices, and public health organizations. The company actively fosters strategic collaborations with numerous partners, such as Bristol-Myers Squibb Company, BioNTech SE, and Merck KGaA. Established in 1849, Pfizer Inc. is headquartered in New York, New York.

Stock ticker
PFE
Company
Pfizer Inc.
Industry
Healthcare
Category
US
Stock split / reverse split
500527
Launch date
Jun 1, 1972
Listed exchange
NYSE

Financials

Q3 FY2026 Earnings
Report period: Sep 29, 2026 – Sep 29, 2026

Summary: PFE reported Revenue of 16.58B (-0.43%), beating expectations; EPS of 0.87 (0.00%), beating expectations.

Revenue (USD)Beat16.58B-0.43%15.85B-3.92%731.14M+4.61%
EPS (USD)Beat0.87+0.00%0.74+16.11%0.14+18.36%
Financial estimates
● Actual● Estimate
Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026
0.62-0.290.47-0.040.56
-20.92%-503.34%-9.55%-108.48%-9.68%
● EPS● YoY
Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026
208.73B208.16B207.62B201.13B204.54B
115.64B121.39B117.21B115.64B115.24B
55.39%58.31%56.45%57.49%56.34%
● Assets● Liabilities● Ratio
Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026
4.60B5.35B2.62B835.00M5.38B
-31.45%-20.42%+11.99%+243.47%+16.77%
● CFO● YoY

Shareholders

Shareholders
BLACKROCK, INC.9.29%
VANGUARD CAPITAL MANAGEMENT LLC6.53%
STATE STREET CORP5.39%
GEODE CAPITAL MANAGEMENT, LLC2.37%
VANGUARD PORTFOLIO MANAGEMENT LLC2.09%
Others74.31%
Institutions
% Owned67.93%+1.84%
Shares held3.87B+104.71M
Institutions2,954-133
% OwnedPrice
Name% OwnedChange
BLACKROCK, INC.9.29%+31.41M
VANGUARD CAPITAL MANAGEMENT LLC6.53%+2.72M
STATE STREET CORP5.39%+5.50M
GEODE CAPITAL MANAGEMENT, LLC2.37%+1.71M
VANGUARD PORTFOLIO MANAGEMENT LLC2.09%+2.50M

Dividends

Dividends
Last ex-dividend: Nov 6, 2026 Cash dividend: 0.43 USD per share
Dividend yield TTM
6.24%
Payout ratio LFY
126.47%
Frequency
Quarterly
20222023202420252026
1.601.641.681.721.72
+3.43%+5.52%+6.28%+7.04%+5.85%
Dividend amount (USD)Dividend yield
Stock splits
Launch date: Jun 1, 1972
DateRatio
Nov 17, 2020500 → 527
Jul 1, 19991 → 3
Jul 1, 19971 → 2
Jul 3, 19951 → 2
Apr 1, 19911 → 2
Jul 1, 19831 → 2
Trade on the go with the OKX app

Pfizer, Inc. performance

€25.53
Pfizer, Inc. price today

Pfizer, Inc. price today is €25.53, marking a -- over the past 24 hours. On OKX, today’s Pfizer, Inc. trading volume reached 18.00, worth over €459.91.

€25.9
Pfizer, Inc. all-time high

Pfizer, Inc. achieved its all-time high price of €25.9 on Nov 18, 2026. At today’s price of €25.53, Pfizer, Inc. price is now -1.46% lower than its historic high.

$28.06
Pfizer, Inc. in USD

The current Pfizer, Inc. to USD conversion rate is $28.06 per Pfizer, Inc..

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.

Guides

Find out how to buy Pfizer, Inc.

Getting started with crypto can feel overwhelming, but learning where and how to buy crypto is simpler than you might think. Kickstart your journey on the OKX mobile app, or right here on the web.

Dive in

Predict Pfizer, Inc.’s prices

How much will Pfizer, Inc. be worth over the next few years? Check out the community’s thoughts and make your predictions.

Forecast

View Pfizer, Inc.’s price history

Track your Pfizer, Inc.’s price history to monitor your holdings’ performance over time. You can easily view the open and close values, highs, lows, and trading volume using the table below.

Check it out

More to explore

Pfizer, Inc. FAQ

Pfizer, Inc. can offer strong returns, but is also subject to market volatility. Whether it’s a good investment depends on your risk tolerance, goals, and market conditions. Pfizer, Inc.’s price can be influenced by various factors such as adoption, regulation, technological advancement, and overall market sentiment. Always do your own research before buying Pfizer, Inc. and never buy more than you can afford to lose. This content is for informational purposes only and isn’t financial advice.

To buy Pfizer, Inc. at a low price, monitor the market closely and use tools like price alerts and technical indicators to keep you updated on price trends. Always do your own research and use secure platforms. This content is for informational purposes only and isn’t financial advice.

Depending on where you’re located, you can use bank transfer, credit/debit card, or Peer-to-Peer. Read our guide on how to use these different payment methods to buy Pfizer, Inc. xPFE safely on a trusted exchange like OKX.

Currently, one Pfizer, Inc. is worth 28.062. For answers and insight into Pfizer, Inc.’s price action, you’re in the right place. Explore the latest Pfizer, Inc. charts and trade responsibly with OKX.

To read this Pfizer, Inc. price chart, hover over or click on the time period you want to view. Hover over the chart to view the corresponding price, displayed in your local currency.

Yes, Pfizer, Inc.’s price is updated in real-time on our Pfizer, Inc. price page. You can view the current price and historical price data here at all times.

Countries and regions differ on how digital assets transactions and holdings are taxed and how they view digital assets in general (money, property, commodity). In general, it is expected that you will pay capital gains tax when selling or swapping Pfizer, Inc. xPFE. Refer here for a more detailed guide.

Staking and earning rewards with Pfizer, Inc. are subject to local restrictions. Log in or sign up to view products available in your country, region, or state of residence.

ESG Disclosure

ESG (Environmental, Social, and Governance) regulations for crypto assets aim to address their environmental impact (e.g., energy-intensive mining), promote transparency, and ensure ethical governance practices to align the crypto industry with broader sustainability and societal goals. These regulations encourage compliance with standards that mitigate risks and foster trust in digital assets.
Read more